ACUTE LYMPHOBLASTIC LEUKEMIAS: BIOMARKERS, MOLECULAR MARKERS, AND MINIMAL RESIDUAL DISEASE IN DIAGNOSIS AND PROGNOSIS

被引：0

作者：

Xu, Jason ^{[1
,2
]}

Sussman, Jonathan ^{[1
]}

Yang, Austin ^{[3
,4
]}

Yoshimura, Satoshi ^{[5
]}

Chen, Changya ^{[2
]}

Elghawy, Omar ^{[6
]}

Vincent, Tiffaney ^{[7
]}

Diorio, Caroline ^{[2
]}

Bandyopadyay, Shovik ^{[3
,4
]}

Hu, Jianzhong ^{[8
]}

Li, Alexander Lai ^{[7
]}

Chen, Gregory M. ^{[9
]}

Chen, Chia-Hui ^{[7
]}

Shraim, Rawan ^{[2
]}

Newman, Haley ^{[2
]}

Ding, Yang ^{[7
]}

Li, Elizabeth ^{[7
]}

Yu, Wenbao

Thadi, Anusha ^{[7
]}

Ahn, Kyung Jin ^{[3
,4
]}

Polonen, Petri ^{[10
]}

Elsayed, Abdelrahman ^{[8
]}

Frank, David ^{[11
]}

Raetz, Elizabeth A. ^{[12
]}

Loh, Mignon L. ^{[13
]}

Wood, Brent L. ^{[14
]}

Winter, Stuart S. ^{[15
]}

Dunsmore, Kimberly P. ^{[16
]}

Devidas, Meenakshi ^{[8
]}

Qu, Chunxu ^{[10
]}

Pounds, Stanley ^{[17
]}

Hunger, Stephen P. ^{[18
]}

Mullighan, Charles G. ^{[10
]}

Yang, Jun J. ^{[5
]}

Tan, Kai ^{[19
]}

Teachey, David T. ^{[20
]}

机构：

[1] Perelman Sch Med, Philadelphia, PA USA

[2] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA USA

[3] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA USA

[4] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA USA

[5] St Jude Childrens Res Hosp, Dept Pharm & Pharmaceut Sci, Memphis, TN USA

[6] Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA USA

[7] Childrens Hosp Philadelphia, Philadelphia, PA USA

[8] St Jude Childrens Res Hosp, Memphis, TN USA

[9] Univ Penn Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA USA

[10] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA

[11] Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA USA

[12] Dept Pediat, NYU Langone Hlth, New York, NY USA

[13] Univ Washington, Seattle Childrens Hosp, Ben Towne Ctr Childhood Canc Res, Fred Hutch Canc Ctr, Seattle, WA USA

[14] Childrens Hosp Angeles, Dept Pathol, Lab Med, Los Angeles, CA USA

[15] Canc & Blood Disorders, Childrens Minnesota, Eagan, MN USA

[16] Univ Virginia Hlth Sci Ctr, Charlottesville, VA USA

[17] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN USA

[18] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA USA

[19] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA USA

[20] Childrens Hosp Philadelphia, Div Oncol, Rutledge, PA USA

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-211090

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

614

引用

页码：1464 / 1465

页数：2

共 50 条

[1] Minimal residual disease in acute lymphoblastic leukemias: biological aspects
Clappier, Emmanuelle
Lhermitte, Ludovic
Kim, Rathana
HEMATOLOGIE, 2020, 26 : 25 - 38
[2] Oligoclonality of acute lymphoblastic leukemias at the TCR delta level: A molecular approach for the diagnosis and detection of minimal residual disease.
PanzerGrumayer, ER
Ghali, D
Stolz, F
Panzer, S
Haas, OA
Fischer, S
Gadner, H
BLOOD, 1996, 88 (10) : 3365 - 3365
[3] New markers for minimal residual disease detection in acute lymphoblastic leukemia
Coustan-Smith, Elaine
Song, Guangchun
Clark, Christopher
Key, Laura
Liu, Peixin
Mehrpooya, Mohammad
Stow, Patricia
Su, Xiaoping
Shurtleff, Sheila
Pui, Ching-Hon
Downing, James R.
Campana, Dario
BLOOD, 2011, 117 (23) : 6267 - 6276
[4] Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
Xia, Min
Zhang, Hong
Lu, Zhenghua
Gao, Yuan
Liao, Xuelian
Li, Hong
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (06) : 418 - 422
[5] Acute myeloid Leukemia: Molecular minimal Residual Disease and Prognosis
Braess, Jan
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (13) : 930 - +
[6] Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
Rzepiel, Andrea
Kutszegi, Nora
Gezsi, Andras
Sagi, Judit C.
Egyed, Balint
Peter, Gyorgy
Butz, Henriett
Nyiro, Gabor
Muller, Judit
Kovacs, Gabor T.
Szalai, Csaba
Semsei, Agnes F.
Erdelyi, Daniel J.
JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
[7] Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
Andrea Rzepiel
Nóra Kutszegi
András Gézsi
Judit C. Sági
Bálint Egyed
György Péter
Henriett Butz
Gábor Nyírő
Judit Müller
Gábor T. Kovács
Csaba Szalai
Ágnes F. Semsei
Dániel J. Erdélyi
Journal of Translational Medicine, 17
[8] THE LIMITATIONS IN UTILIZING PHENOTYPIC MARKERS TO DETECT MINIMAL RESIDUAL DISEASE IN ACUTE LEUKEMIAS (AL)
BERNARD, A
PATHOLOGIE BIOLOGIE, 1988, 36 (01): : 17 - 20
[9] Acute Lymphoblastic Leukemia Blinatumomab improved Prognosis for Children with minimal Residual Disease
Schmale, Ine
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (7-8) : 450 - 451
[10] Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia
Chen, JS
Coustan-Smith, E
Suzuki, T
Neale, GA
Mihara, K
Pui, CH
Campana, D
BLOOD, 2001, 97 (07) : 2115 - 2120

← 1 2 3 4 5 →